Business Standard

Saturday, December 21, 2024 | 01:19 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Britain moves closer to Covid-19 vaccine trials that infect volunteers

If agreed, this would involve creating a human challenge study model that could be used should such trials gain ethical and safety approval from regulators

UK Covid
Premium

Supporters of human challenge trials say they are a good way to cut short the often lengthy process of testing potential vaccines

Kate Kelland | Reuters London
“Human challenge” trials of potential Covid-19 vaccines, where volunteers are deliberately infected with the disease, could become a reality after a British biotech firm said it was in advanced talks with the government to create and provide strains of the virus.
 
Preliminary work for the trials, which aim to speed up the process of determining the efficacy of a vaccine candidate, is being carried out by hVIVO, a unit of pharmaceutical services group Open Orphan, the company said. “We are in discussions with numerous parties including the UK government around a Covid-19 challenge study, and once any of those contracts

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in